KALA BIO, Inc.
Pharmaceutical Preparations · ARLINGTON · MA
Moderate confidence (50%)
Updated Oct 16, 2026, 12:04 AM
What is happening
Derived by rule set status-rules-2026.09.7
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
Latest material event: KALA BIO, Inc. received a delisting notice from its exchange (Aug 27, 2026)
Timeline
Every material event, newest first. History is never overwritten.
KALA BIO, Inc. received a delisting notice from its exchange
Aug 27, 2026
Delisting notice received
- SEC EDGAR — “Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On August 27, 2026, KALA BIO, Inc. (the Company ) received a letter (the Staff Determination Letter ) from the Listing Qualifications Department (the Staff ) of The Nasdaq Stock Market LLC ( Nasdaq ) notifying the Company that the Staff has determined that the closing bid price of the Company s common stock, par value $0.001 per share (the Common Stock ), has been below $1.00 per share for the previous 30 consecutive business days (from July 16, 2026 through August 26, 2026) and, as a…”
KALA BIO, Inc. received a delisting notice from its exchange
Jan 20, 2026
Delisting notice received
- SEC EDGAR — “Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On January 20, 2026, KALA Bio, Inc. (the Company ) received a letter from the Listing Qualifications Department of the Nasdaq Stock Market indicating that, based upon the closing bid price of the Company s common stock for the 30 consecutive business days between December 3, 2025, to January 16, 2026, the Company did not meet the minimum bid price of $1.00 per share required for continued listing on The Nasdaq Capital Market ( Nasdaq ) pursuant to Nasdaq Listing Rule 5550(a)(2). The l…”
Company information
- Founded
- —
- Employees (estimate)
- —
- Industry
- Pharmaceutical Preparations
- Subindustry
- —
- Listing
- SEC lists the ticker KALA on Nasdaq.
- SEC CIK
- 0001479419
- Website
- —
- —
- Headquarters
- ARLINGTON, MA
- Also known as
- KALA BIO, Inc., Kala Pharmaceuticals, Inc.
- Legal entities
- KALA BIO, Inc.
Sources
Every material source used to build this profile.
SEC Company Submissions (TIER 1 · UNVERIFIED)
KALA BIO, Inc. — Pharmaceutical Preparations (SIC 2834) — ARLINGTON, MA
View source recordSEC EDGAR (TIER 1 · UNVERIFIED)
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On January 20, 2026, KALA Bio, Inc. (the Company ) received a letter from the Listing Qualifications Department of the Nasdaq Stock Market indicating that, based upon the closing bid price of the Company s common stock for the 30 consecutive business days between December 3, 2025, to January 16, 2026, the Company did not meet the minimum bid price of $1.00 per share required for continued listing on The Nasdaq Capital Market ( Nasdaq ) pursuant to Nasdaq Listing Rule 5550(a)(2). The l…
View source recordSEC EDGAR (TIER 1 · UNVERIFIED)
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On August 27, 2026, KALA BIO, Inc. (the Company ) received a letter (the Staff Determination Letter ) from the Listing Qualifications Department (the Staff ) of The Nasdaq Stock Market LLC ( Nasdaq ) notifying the Company that the Staff has determined that the closing bid price of the Company s common stock, par value $0.001 per share (the Common Stock ), has been below $1.00 per share for the previous 30 consecutive business days (from July 16, 2026 through August 26, 2026) and, as a…
View source record
Status history
Every derived status, with the rule that produced it.
- DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:31 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:11 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 15, 2026, 12:33 PM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 14, 2026, 04:46 PM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- UNKNOWN → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 8, 2026, 03:37 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.